Sera Prognostics (SERA) Company Sales Volume

seraprognostics.com - graphic logo of issuer SERA

Sera Prognostics is optimizing resources by outsourcing its manufacturing and clinic operations to third-party contractors. The company's sales trends confirm the effectiveness of this model, where the 0.00 mark reflects the latest data. This leader in predictive diagnostics helps physicians reduce the risks of premature birth, and the business is currently scaling the integration of its tests into US insurance standards.

Sera Prognostics, Inc. (SERA) Revenue and Sales Volume: for the period 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Sera Prognostics, Inc. (SERA)

- market price and analyst price targets:
Market Price seraprognostics.com|SERA - Price Target Chart
- market capitalization details:
Market Capitalization Sera Prognostics, Inc.|SERA - Total Company Value
- issuer book value statistics:
Net Assets per Share Sera Prognostics|SERA - Book Capitalization|Market-to-Book Ratio seraprognostics.com|SERA - Aggregate Company Assets
- company liabilities and liquidity data:
All Debt to Shareholders' Equity Ratio Sera Prognostics|SERA - Long-Term Debt to Capital|Short-Term Debt to Capital Sera Prognostics Inc.|SERA - Company Total Debt|Debt to Net Assets Ratio Sera Prognostics, Inc.|SERA - Company Long-Term Debt|Current Liabilities Sera Prognostics|Intermediate Coverage Ratio seraprognostics.com
- earnings and market multiples details:
SERA - Company Net Income|Expected Net Profit Sera Prognostics|SERA - P/E Multiple|Forward Price to Earnings Multiple seraprognostics.com|SERA - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Sera Prognostics, Inc.|SERA - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Sera Prognostics|SERA - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months seraprognostics.com|SERA - Net earnings per share growth this year|Projected earnings per share increase next year Sera Prognostics
- company sales and revenue statistics:
SERA - Revenue and Sales Volume|Company Future Sales Sera Prognostics Inc.|SERA - P/S Multiple|Forward Price-to-Revenue Multiple Sera Prognostics, Inc.
General company analysis:seraprognostics.com - SERA
Flagship merchandise of Sera Prognostics, Inc.

Investors assess fundamental capital risks through the dynamics of actual cash inflows. For Sera Prognostics (SERA), the commercialization of the PreTRM test and the expansion of insurance coverage serve as critical factors. By analyzing the company's trading revenue, the user compares daily shipment volumes with management's planned targets. This metric measures actual demand for diagnostics, filtering out market noise. Steady growth on the chart confirms the product's integration into government protocols.

Analysis of competing companies

Company Total Revenue Natera Medical NTRA|Company Revenue Humacyte, Inc. (HUMA)